UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
Collateral Therapeutics, Inc.
---------------------------------------------------------
(Name of Issuer)
Common Stock
---------------------------------------------------------
(Title of Class of Securities)
193921 10 3
---------------------------------------------------------
(CUSIP Number)
June 24, 1998
---------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[X] Rule 13d-1(d)
Page 1 of 5
<PAGE>
CUSIP No. 193921 10 3 13G Page 2 of 5 Pages
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON(S)
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON(S)
Schering Berlin Venture Corporation
22-3265060
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER
SHARES 1,584,676
BENEFICIALLY --------------------------------------------------------------
OWNED BY 6. SHARED VOTING POWER
EACH - 0 -
REPORTING --------------------------------------------------------------
PERSON 7. SOLE DISPOSITIVE POWER
WITH 1,584,676
--------------------------------------------------------------
8. SHARED DISPOSITIVE POWER
- 0 -
- --------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,584,676
- --------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
Not Applicable
- --------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
15.0%
- --------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
CO
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
Page 2 of 5
<PAGE>
Item 1.
(a) Name of Issuer: Collateral Therapeutics, Inc.
(b) Address of Issuer's Principal Executive Offices:
9360 Towne Centre Drive, San Diego, CA 92121
Item 2.
(a) Name of Person Filing: Schering Berlin Venture Corp.
(b) Address of Principal business Office or, if none, Residence:
110 East Hanover Avenue, Cedar Knolls, NJ 07929
(c) Citizenship: Delaware
(d) Title of Class of Securities: Common Stock, par value $0.001.
(e) CUSIP Number: 193921 10 3
Item 3.
Not applicable. This Schedule 13G was filed pursuant to Rule 13d-1(d).
Item 4. Ownership
Provide the following information regarding the aggregate number and
percentage of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned: 1,584,676 shares of Common Stock.
(b) Percent of class: 15.0%.
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote: 1,584,676.
(ii) Shared power to vote or to direct the vote: 0.
(iii) Sole power to dispose or to direct the disposition of:
1,584,676.
(iv) Shared power to dispose or to direct the disposition of: 0.
Item 5. Ownership of Five Percent or Less of a Class
Not Applicable
Item 6. Ownership of More than Five Percent on Behalf of Another Person
Not Applicable
Item 7. Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on By the Parent Holding Company
Not Applicable
Page 3 of 5
<PAGE>
Item 8. Identification and Classification of Members of the Group
Not Applicable
Item 9. Notice of Dissolution of Group
Not Applicable
Item 10. Certification
Not Applicable
Page 4 of 5
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.
---------------------------------------
Date
---------------------------------------
Signature
---------------------------------------
Robert A. Chabora/Secretary
Name/Title
Attention: Intentional misstatements or omissions of fact constitute
Federal criminal violations (See 18 U.S.C. 1001)
Page 5 of 5
